期刊
GLIA
卷 69, 期 6, 页码 1341-1368出版社
WILEY
DOI: 10.1002/glia.23940
关键词
astrocytes; experimental autoimmune encephalomyelitis; glial scar; multiple sclerosis; reactive gliosis
资金
- Clinical Academic Center (2CA-Braga) [EXPL/001/2016]
- Fundacao para a Ciencia e a Tecnologia [CEECIND/01084/2017, EXPL/NEU-OSD/2196/2013, NORTE01-0145-FEDER-000013, PD/BD/114120/2015]
- Fundação para a Ciência e a Tecnologia [EXPL/NEU-OSD/2196/2013, PD/BD/114120/2015] Funding Source: FCT
Multiple sclerosis is a chronic inflammatory disease of the central nervous system that affects about 2.5 million people worldwide. There is currently no cure for MS and the available treatments only slow the initial phases of the disease. Disease progression and disability in MS are better correlated with the maintenance of a persistent low-grade inflammation inside the CNS, driven by local glial cells like astrocytes.
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) that affects about 2.5 million people worldwide. In MS, the patients' immune system starts to attack the myelin sheath, leading to demyelination, neurodegeneration, and, ultimately, loss of vital neurological functions such as walking. There is currently no cure for MS and the available treatments only slow the initial phases of the disease. The later-disease mechanisms are poorly understood and do not directly correlate with the activity of immune system cells, the main target of the available treatments. Instead, evidence suggests that disease progression and disability are better correlated with the maintenance of a persistent low-grade inflammation inside the CNS, driven by local glial cells, like astrocytes and microglia. Depending on the context, astrocytes can (a) exacerbate inflammation or (b) promote immunosuppression and tissue repair. In this review, we will address the present knowledge that exists regarding the role of astrocytes in MS and experimental animal models of the disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据